We found 195 records for "Licensing / acquisition"

Articles

Does the drug industry need a new pricing model?

12th January 2015

 Does the drug industry need a new pricing model?Articles

Various approaches have been taken to try to balance the rising costs of new medicines with tightening healthcare budgets, but few have proved effective long-term. Advances in drug development are...

Read more

20 People who shaped healthcare in 2014 (Part 4)

2nd January 2015

 20 People who shaped healthcare in 2014 (Part 4)Articles

In the final instalment of our review of 2014, Andrew McConaghie looks at how patient advocates in rare diseases and 'activist investors' have shaped healthcare – and will continue to...

Read more

Selling science to potential investors and partners

12th September 2014

 Selling science to potential investors and partnersArticles

Start-ups and biotechs often need the support of outside investors to take their innovations to the next level. So what are the considerations when preparing a presentation for these important...

Read more

Adaptive Licensing: Could patients be the answer to the data problem?

4th August 2014

 Adaptive Licensing: Could patients be the answer to the data problem?Articles

Patients could play a key role in generating the data required to make Europe's Adaptive Licensing a success.The timing of patient access to new medicines has always been one of...

Read more

News

Allergan deal will go ahead, says Pfizer chief

3rd February 2016

 Allergan deal will go ahead, says Pfizer chiefNews

Pfizer's chief executive Ian Read says his company's $160 billion takeover of Allergan will not be blocked by US politicians.The deal was announced in November last year, and will see...

Read more

Acorda aims for leadership in Parkinson's disease with acquisition

20th January 2016

 Acorda aims for leadership in Parkinson's disease with acquisitionNews

US specialist pharma company Acorda is to acquire Biotie for $363 million, a move which it hopes will make it a leader in Parkinson's disease treatments.The neurological movement disorder affects...

Read more

Novartis extends immuno-oncology investment

11th January 2016

 Novartis extends immuno-oncology investmentNews

Novartis has added another immuno-oncology deal to its R&D efforts, a further sign of the area's central importance to the sector.A new collaboration and licensing agreement with Cambridge, Massachusetts-based Surface Oncology...

Read more

Sanofi exits insulin flop Afrezza, MannKind shares dive

5th January 2016

 Sanofi exits insulin flop Afrezza, MannKind shares diveNews

MannKind, the company that developed inhaled insulin Afrezza, has announced that its co-marketing deal with Sanofi is to end, after the drug proved a commercial failure.The California-based firm says its...

Read more

White Papers

All change for pharma and biotech partnerships

30th September 2013

 All change for pharma and biotech partnershipsWhite Papers

The pharma industry is always evolving, and in the past decade, there has been an increasing reliance on partnering to strengthen R&D. In this original white paper, Phenestra shares its...

Read more

Audio & Video

Live webinar/debate - Feb 4th - COPD, connecting real world needs to patient centric solutions

    COPD is a widespread, costly and largely preventable condition which affects over 300 million people worldwide and is recognised as the ‘third-leading’ cause of death in most countries. Adherence rates...

Read more

On demand webinar: The Price is Right? - Delivering UK access for niche patient populations

  With challenges to highly priced rare disease medicines and the Cancer Drug Fund evolving again – what is next, what are the ramifications for high priced/innovative treatments delivering beneficial outcomes...

Read more

Press Releases

Physicians Interactive Advances Global Health Digital Engagement by Acquiring Univadis

22nd October 2015

Physicians Interactive Advances Global Health Digital Engagement by Acquiring Univadis

Physicians Interactive Advances Global Health Digital Engagement by Acquiring UnivadisAuthoritative Medical Content Platform Combined with Deep Digital Expertise Offers Greater Opportunities to Engage Healthcare Professionals and Improve Outcomes READING, Mass. –...

Read more

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

15th April 2015

Arthur G. Cook (ZS Associates) publishes 2nd Edition with Gower

  The eagerly awaited second edition of Arthur G. Cook's Forecasting for the Pharmaceutical Industry is now available from Gower.     Forecasting for the Pharmaceutical Industry is a definitive guide for forecasters as...

Read more

New Schoonveld book is now available!

10th December 2014

New Schoonveld book is now available!

It's here!   The eagerly awaited new editon of THE PRICE OF GLOBAL HEALTH  is now available.   Written by global drug pricing expert Ed Schoonveld, The Price of Global Health (second edition) is...

Read more